Aloop Therapeutics ApS

CVR 43257498 · Private limited company (ApS) · Active · Low risk

Aloop Therapeutics ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 30.7m and a net result of DKK -70k.

Bankruptcy risk for Aloop Therapeutics ApS

0.1%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 33% of active Danish companies

Lowest riskHighest risk

Increases the risk

Moves in the last 2 years2 · bankruptcy rate 23.9%2.7×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of CEOs0 · bankruptcy rate 12.7%1.4×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Number of auditors (historical)1 · bankruptcy rate 6.2%0.70×
Return on assets-20%–0% · bankruptcy rate 6.2%0.70×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
43257498
Status
Active
Company type
Private limited company (ApS)
Founded
(4 years)
Address
c/o CSC (DENMARK) ApS, Sundkrogsgade 21
2100 København Ø
Municipality
København
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 300k
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityNo
Equity ratio99.4%
Current ratio16,942%
Moves (last 2 years)2
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address472
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK -274kDKK -1.3mDKK -9.1m
Net profitDKK -70kDKK -1.3mDKK -8.8m
EquityDKK 30.7mDKK 30.7mDKK 32.0m
Total assetsDKK 30.8mDKK 30.8mDKK 34.3m
CashDKK 30.7mDKK 30.2m–
Short-term debtDKK 182kDKK 87k–
Tax owedDKK 29k––
Avg. employees0––

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025175
1 Jan 2024 – 31 Dec 2024144
1 Jan 2023 – 31 Dec 202361
6 May 2022 – 31 Dec 202279

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOThomas Kirkegaard Jensen
BoardCamilla Petrycer Hansen
BoardJens Bo Rode Hansen
BoardEmmanuelle Coutanceau
BoardCamilla Petrycer Hansen
Owner (100%)Coave TherapeuticsCurrent
Owner (100%)Novo Holdings A/S
AuditorPKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab
FounderNovo Holdings A/SCurrent

The CEOs' other companies

Thomas Kirkegaard Jensen – 4 other companies

Address history (4 moves)

c/o CSC (DENMARK) ApS, Sundkrogsgade 21, 2100 København Ø
Nordre Fasanvej 215, 2000 Frederiksberg
c/o Cobis, Ole Maaløes Vej 3, 2., 2200 København N
Stærmosevej 12, 7120 Vejle Øst
Tuborg Havnevej 19, 2900 Hellerup

Other companies at the same address

Similar companies in København

Questions and answers about Aloop Therapeutics ApS

Has Aloop Therapeutics ApS gone bankrupt?

No, Aloop Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Aloop Therapeutics ApS?

Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

When was Aloop Therapeutics ApS founded?

Aloop Therapeutics ApS was founded on 6 May 2022.

What is the equity of Aloop Therapeutics ApS?

Equity was DKK 30.7m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.